Most readers would already be aware that BioMarin Pharmaceutical's (NASDAQ:BMRN) stock increased significantly by 10% over the past three months.Check out our latest analysis for BioMarin Pharmaceutical  The formula for ROE is: Return on Equity = Net Profit (from continuing operations) รท Shareholders' Equity So, based on the above formula, the ROE for BioMarin Pharmaceutical is: 3.5% = US$114m รท US$3.2b (Based on the trailing twelve months to March 2020).